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Radiation therapy, along with surgery and chemotherapy, are the major therapeutic strategies for cancer treatment. It involves the delivery of
ionizing radiation with high accuracy to the tumor tissue, resulting in the death of tumor cells. Radiation sensitization is a process of
enhancing the susceptibility of tumor tissues to injury by radiation exposure. Hence, radiation sensitizers are therapeutic or otherwise inert
agents that enhance the effects of radiation therapy. Iron oxide nanoparticles, a type of magnetic nanoparticle (MNP), are amongst the
nanomaterials which have been suggested as radiation sensitizers (Figure 1).1 Hyperthermia is a type of cancer treatment in which tissue is
exposed to elevated temperatures. Hyperthermia is almost always used with other forms of cancer therapy, such as radiation therapy and
chemotherapy. Hyperthermia may make some cancer cells more sensitive to radiation. When hyperthermia and radiation therapy are
combined, they are often given within an hour of each other. MNP can induce localized hyperthermia when exposed to an alternating
magnetic field (AMF).3,4 As MNP are potentially capable of producing two sensitization effects (x-ray interaction and hyperthermia
generation) they are particularly attractive for this application.
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Cell lines: Chinese hamster ovary (CHO) and MTGB (a murine mammary adenocarcinoma 
cell line) will be incubated for 72 hrs with 1 mg/mL of MNP to allow for intracellular uptake 
(Figure 2). Each flask will be rinsed with PBS to remove extracellular MNP and given new 
media prior to irradiation. Variables: CHO, MTGB.
Fe3O4 Nanoparticles: MNP are promising materials for hyperthermia treatment, as well as 
radiation sensitizing agents. Relative to other nanoparticles considered for radiation 
sensitization, they are highly biocompatible, and well suited for adjuvant hyperthermia 
applications.6 The particles used for these studies are BNF-Dextran plain, 84-00-102, 
(micromod GmbH, Rostock, Germany). These particles have a hydrodynamic radius of 100 
nm, and are suspended in water at 25 mg/ml. Variables: cell incubation +MNP, cell 
incubation -MNP.
Irradiation: Cells will be irradiated with a Kubtec XCELL 50 kVP cell irradiator (Kubtec 
Scientific, Stratford, CT). Variables: 0 Gy, 3 Gy, 6 Gy.
Hyperthermia: Cells will be held at 45°C for 30 minutes either one hour before or one hour 
after irradiation with use of a water bath. Variables: Hyperthermia before irradiation, 
Hyperthermia after irradiation, No hyperthermia.
Cytotoxicity assays: Whether the cytotoxicity of is increased by the presence of MNP will 
be examined through the CCK-8 assay, the trypan blue assay, and colony forming assay to 
measure the cytotoxicity of MNP and hyperthermia.
Figure 1: Left: Summary of various nanomaterial-based approaches for enhancing the radiosensitization in cancer cells. Right: Possible x-ray interactions 
with high Z materials. These interactions may result in the production of electrons, positrons or photons that may subsequently damage nearby DNA within 
cancer cells, resulting in cell death.1
.
Hypothesis: the combination of MNP and ionizing radiation increases the cytotoxicity of hyperthermia.
(Kwatra 2013)(Kwatra 2013)
Figure 2: Transmission electron microscopy image
of MNP located within an MTGB mouse
mammary adenocarcinoma cell, following
intratumoral injection. The clustering and
intracellular uptake near nucleus may enhance the
cytotoxicity of radiation therapy.
Future work: Magnetic nanoparticles  are promising materials for hyperthermia treatment, as well as radiation sensitizing agents. If 
cytotoxicity is demonstrated in these studies, future work determine the mechanism of action. The subsequent studies will determine if reactive 
oxygen species (ROS) are increased with the combination of MNP, hyperthermia. By increasing the DNA damage due to ROS, MNP may have 
the potential to potentiate local radiation. 
